This combined panel was capable of predicting new cases of type 2 diabetes over a 5-years follow-up period with a specificity and sensitivity similar to classic diabetes predictors (serum adiponectin, insulin resistance, impaired glucose tolerance and impaired fasting glycaemia). This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.